Effect of tetramethylpyrazine and hyperlipidemia on hepcidin homeostasis in mice
- 1 November 2018
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 43 (1) , 501-506
Abstract
Iron homeostasis is strictly regulated in mammals, and disordered iron metabolism is recognized as a risk factor for various diseases, including cardiovascular disease. The hepcidin-ferroportin axis is the key signaling mechanism that controls systemic iron homeostasis. Increased serum hepcidin is associated with multiple types of cancer and atherosclerosis (AS), and therapeutics that decrease hepcidin levels have been proposed to treat these diseases. However, the effects of abnormal circulating hepcidin on hyperlipidemia remain unexploited. The natural compound tetramethylpyrazine (TMP) has been reported to have therapeutic effects on cardiovascular diseases, whereas the mechanisms involved remain incompletely understood. Thus, the effects of TMP on the expression of hepcidin in hyperlipidemic mice were investigated and the mechanisms involved were explored. Hyperlipidemia increased serum hepcidin, which was inhibited by TMP intervention. The results also indicated that TMP may decrease hepcidin expression via inhibition of Stat3 signaling. These findings suggest a promising rationale to prevent and hyperlidemia by targeting hepcidin or its upstream regulators, and highlight the potential application of natural compounds in treating hepcidin disorder-associated diseases.Keywords
This publication has 32 references indexed in Scilit:
- Hepcidin and iron regulation, 10 years laterBlood, 2011
- Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in miceHepatology, 2011
- Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain functionAdvances in Nutrition, 2011
- In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2Blood, 2010
- Ferroportin and Iron Regulation in Breast Cancer Progression and PrognosisScience Translational Medicine, 2010
- Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 BindingCancer Research, 2009
- Deficiency of heme-regulated eIF2 kinase decreases hepcidin expression and splenic iron in HFE-/- miceHaematologica, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- The function of heme-regulated eIF2α kinase in murine iron homeostasis and macrophage maturationJournal of Clinical Investigation, 2007
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003